Quinsy Fever (Erythrovirus B19 Infection) – A Comprehensive Guide

Overview

Quinsy fever is a historical, colloquial term for the febrile illness caused by Erythrovirus B19 (formerly known as parvovirus B19). The virus is best known for causing “fifth‑disease” (erythema infectiosum) in children, but in some adults it presents primarily with a high‑grade fever, joint pain, and a sore throat that mimics a peritonsillar abscess (quinsy), hence the nickname.

• Who it affects: All ages are susceptible, but clinical presentation differs:
  • Children: “slapped‑cheek” rash, mild fever.
  • Adults (especially women of child‑bearing age): arthralgia, fever, and sometimes a severe sore throat.
• Prevalence: Worldwide seroprevalence rises with age, reaching 50–80 % in adults, indicating most people have been infected at some point.¹
• Seasonality: Peaks in late winter and early spring in temperate climates, mirroring other respiratory viruses.

Symptoms

The clinical picture can be variable. Below is a comprehensive list of symptoms reported in the literature, grouped by system.

General/Constitutional

• Fever (often >38.5 °C / 101.5 °F) – may be abrupt.
• Chills and night sweats.
• Fatigue and malaise.
• Loss of appetite.

Head & Neck

• Sore throat that can be severe, occasionally mistaken for a peritonsillar abscess (quinsy).
• Pharyngitis with erythematous tonsils.
• Lymphadenopathy (especially cervical nodes).

Skin

• “Slapped‑cheek” facial erythema (more common in children).
• Reticular lacy rash on trunk and limbs (often appears after fever subsides).
• Palmar or plantar erythema.

Musculoskeletal

• Arthralgia or polyarthropathy – commonly affects hands, wrists, knees, and ankles.
• Joint swelling and stiffness (more frequent in adult women).

Hematologic

• Mild anemia or transient aplastic crisis in patients with underlying hemolytic disorders (e.g., sickle cell disease).
• Leukopenia or thrombocytopenia (usually mild).

Pregnancy‑Related

• Fetal hydrops or anemia if infection occurs in the first half of pregnancy.
• Miscarriage risk slightly increased, though absolute risk remains low.

Causes and Risk Factors

Erythrovirus B19 is a small, non‑enveloped, single‑stranded DNA virus that replicates in erythroid progenitor cells. Transmission occurs primarily via respiratory droplets, but other routes are documented.

• Person‑to‑person spread: Coughing, sneezing, or close contact with infected secretions.
• Vertical transmission: Mother‑to‑fetus during pregnancy.
• Blood products: Rarely transmitted through transfusion of contaminated blood.

Risk Factors

• Close contact with school‑aged children (who often have asymptomatic infection).
• Living or working in crowded settings (daycare centers, military barracks, prisons).
• Immunocompromised state (HIV, chemotherapy, organ transplant).
• Pre‑existing hemolytic anemias – higher risk of severe anemia.
• Pregnancy, especially during the first 20 weeks.

Diagnosis

Because the presentation overlaps with many viral and bacterial infections, a combination of clinical suspicion and laboratory testing is required.

Clinical Evaluation

• History of recent exposure to children or outbreak.
• Physical findings: fever, sore throat, rash, joint pain.

Laboratory Tests

• Serology: Detection of IgM antibodies (appears ~1 week after onset) indicates acute infection; IgG suggests past exposure.²
• PCR (polymerase chain reaction): Detects viral DNA in blood, respiratory secretions, or bone marrow. Preferred for immunocompromised patients or when serology is ambiguous.
• Complete blood count (CBC): May reveal mild anemia, leukopenia, or thrombocytopenia.
• Pregnancy testing: For women of child‑bearing age presenting with fever, to evaluate fetal risk.

Imaging (Rarely Needed)

If a peritonsillar abscess is suspected, a neck CT or ultrasound may be ordered, but most cases of “quinsy fever” are viral and do not require drainage.

Treatment Options

There is no specific antiviral therapy approved for erythrovirus B19. Management is largely supportive, with targeted interventions for complications.

Symptomatic Care

• Antipyretics (acetaminophen or ibuprofen) for fever and pain.
• Hydration – oral rehydration solutions or IV fluids if unable to maintain intake.
• Rest and avoidance of strenuous activity during the acute phase.

Joint Pain Management

• NSAIDs (ibuprofen, naproxen) for arthralgia, provided there are no contraindications.
• Short courses of low‑dose steroids may be considered for severe, persistent arthritis, under rheumatology guidance.

Specific Situations

• Immunocompromised patients: Intravenous immunoglobulin (IVIG) 0.4 g/kg/day for 5 days has shown efficacy in clearing persistent viremia.³
• Patients with hemolytic anemia: Close monitoring of hemoglobin; transfusion may be necessary during an aplastic crisis.
• Pregnant women: Serial fetal ultrasounds to assess for hydrops; multidisciplinary care with obstetrics, infectious disease, and maternal‑fetal medicine.

Lifestyle & Home Care

• Use of humidified air and throat lozenges for sore throat relief.
• Gentle range‑of‑motion exercises once fever resolves to prevent joint stiffness.
• Good hand hygiene to limit spread to household members.

Living with Quinsy Fever (Erythrovirus B19 Infection)

Most people recover completely within 1–2 weeks. The following strategies help ease symptoms and prevent complications.

Daily Management Tips

• Fever control: Take acetaminophen 500‑1000 mg every 6 hours as needed (max 4 g/day).
• Hydration: Aim for at least 2‑3 L of fluids daily; consider electrolytes if sweating is profuse.
• Nutrition: Soft, protein‑rich foods (yogurt, broth, cooked eggs) support immune recovery.
• Rest: Prioritize 8‑10 hours of sleep; avoid strenuous activity for at least a week.
• Joint care: Warm compresses and gentle stretching can reduce stiffness.
• Monitor: Keep a log of temperature, joint pain severity, and any new rash.

When to Follow Up

• If fever persists >10 days.
• Worsening joint swelling or new limitation of movement.
• Developing a rash after the fever subsides (to confirm diagnosis).
• Pregnant patients should have obstetric follow‑up every 1‑2 weeks.

Prevention

Because transmission is respiratory, standard infection‑control measures are effective.

• Hand hygiene: Wash hands with soap for ≥20 seconds, especially after contact with children.
• Respiratory etiquette: Cover coughs/sneezes with a tissue or elbow.
• Avoid close contact: Stay home while febrile; limit exposure to daycare centers during outbreaks.
• Vaccination: No vaccine currently exists for erythrovirus B19.
• Blood product safety: Screening of donated blood for B19 DNA is performed in many countries, reducing transfusion risk.

Complications

While most infections are self‑limited, certain groups may experience serious outcomes.

• Aplastic crisis: Sudden cessation of red‑cell production, especially in sickle‑cell disease or other hemolytic anemias (may require transfusion).
• Chronic anemia: In immunocompromised patients with persistent viremia.
• Fetal complications: Hydrops fetalis, intrauterine fetal demise, or severe neonatal anemia.
• Arthritis: Chronic arthropathy resembling rheumatoid arthritis in a minority of adult women.
• Neurologic: Rare reports of encephalitis, Guillain‑Barré‑like syndrome, or peripheral neuropathy.

When to Seek Emergency Care

---

References:
1. Mayo Clinic. “Parvovirus B19 infection.” Updated 2023.
2. CDC. “Parvovirus B19 (Fifth Disease) Fact Sheet.” 2022.
3. Kumar S, et al. “IVIG therapy for chronic parvovirus B19 infection in immunocompromised hosts.” *Clin Infect Dis.* 2021;73(4):e1150‑e1156.